Aclarion, Inc. (NASDAQ:ACONW) Short Interest Update

Aclarion, Inc. (NASDAQ:ACONW) was the recipient of a significant decline in short interest in August. As of August 31st, there was short interest totaling 69,875 shares, a decline of 69.9% from the August 15th total of 231,797 shares. Based on an average daily volume of 8,378 shares, the short-interest ratio is presently 8.3 days.

Aclarion Price Performance

Shares of ACONW traded up $0.00 during mid-day trading on Friday, hitting $0.03. 241 shares of the company’s stock were exchanged, compared to its average volume of 21,678. Aclarion has a fifty-two week low of $0.02 and a fifty-two week high of $0.23. The business’s 50 day moving average is $0.03 and its two-hundred day moving average is $0.03.

Aclarion Company Profile

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc and changed its name to Aclarion, Inc in December 2021.